WellBeam has successfully secured $10 million in Series A financing to enhance its healthcare technology solutions, emphasizing interoperability and electronic medical record integration.
Target Company Overview
WellBeam is a healthcare technology firm focused on enhancing clinical care management by fostering seamless interoperability and integrating electronic medical records (EMR) between acute and post-acute care providers. With the aim of bridging gaps in healthcare delivery, WellBeam is committed to improving patient outcomes through advanced technology solutions.
The company is at the forefront of transforming healthcare interactions, thus positioning itself as a critical player in the evolving landscape of healthcare technology. Its innovative solutions not only streamline processes but also ensure that care teams have access to vital patient information, facilitating improved communication and coordination.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare technology industry in the United States has witnessed significant growth, especially in the wake of the COVID-19 pandemic. The demand for high-quality healthcare services has surged, leading to a
Similar Deals
Broadview Ventures and Advent Life Sciences → Relief Cardiovascular
2025
SPRIM Global Investments and William Taylor Nominees → RheumaGen, Inc.
2025
Five Elms Capital → Motivity
2025
Ballast Point Ventures → Medsender
2025
Wittington Ventures
invested in
WellBeam
in 2025
in a Series A deal
Disclosed details
Transaction Size: $10M